Humana declares quarterly dividend of $0.885 per share

Published 04/15/2026, 05:04 PM
© Reuters.

LOUISVILLE, Ky. - Humana Inc. (NYSE:HUM) announced its board of directors declared a cash dividend of $0.885 per share, according to a press release statement. This continues the company’s consistent dividend track record, having maintained payments for 16 consecutive years, according to InvestingPro data. The dividend represents a yield of 1.8% based on the current stock price of $198.37.

The dividend will be paid on July 31, 2026 to stockholders of record as of the close of business on June 26, 2026.

Humana is a healthcare company that provides insurance services and healthcare services to Medicare and Medicaid beneficiaries, families, individuals, and military service personnel. With a market capitalization of $23.8 billion, InvestingPro analysis indicates the stock appears undervalued based on its Fair Value assessment. For deeper insights, investors can access Humana’s comprehensive Pro Research Report, available for this and 1,400+ other US equities.

In other recent news, Humana Inc. has announced a partnership with Tuesday Health to expand value-based palliative care services to eligible Humana members in Texas. This program, set to launch on June 1, 2026, will include coordinated clinical guidance and support services delivered by interdisciplinary care teams. Additionally, Humana has elected healthcare investor Robert S. Field to its board of directors, effective immediately following the company’s 2026 annual meeting of stockholders.

Mizuho has lowered its price target for Humana to $258 from $310, maintaining an Outperform rating, citing risks associated with Medicare Advantage. Meanwhile, Cantor Fitzgerald reiterated a Neutral rating on Humana with a $201 price target, expressing concerns about the company’s 2026 Medicare Advantage margins. The firm highlighted that while Humana’s membership grew significantly, concerns remain about the richness of benefit design for new members.

Furthermore, Humana is facing increased scrutiny as the Centers for Medicare & Medicaid Services (CMS) expands its RADV audits. The company will see 42 contracts audited for 2020, a significant increase from 9 in 2018, representing 99% of its total membership within those named contracts. These developments provide a snapshot of Humana’s current strategic and financial landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.